These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 19266536)

  • 1. Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects.
    Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ
    Prenat Diagn; 2009 Jun; 29(6):570-7. PubMed ID: 19266536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second trimester two-step trisomy 18 screening using maternal serum markers.
    Muller F; Sault C; Lemay C; Roussel-Mizon N; Forestier F; Frendo JL;
    Prenat Diagn; 2002 Jul; 22(7):605-8. PubMed ID: 12124697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using second trimester ultrasound and maternal serum biomarker data to help detect congenital heart defects in pregnancies with positive triple-marker screening results.
    Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ
    Am J Med Genet A; 2008 Oct; 146A(19):2455-67. PubMed ID: 18785270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters.
    Zhang J; Lambert-Messerlian G; Palomaki GE; Canick JA
    Prenat Diagn; 2011 Jun; 31(6):583-8. PubMed ID: 21480302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second trimester levels of pregnancy associated plasma protein-A in cases of trisomy 18.
    Spencer K; Crossley JA; Green K; Worthington DJ; Brownbill K; Aitken DA
    Prenat Diagn; 1999 Dec; 19(12):1127-34. PubMed ID: 10590430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-trimester maternal serum analyte levels associated with fetal trisomy 13.
    Saller DN; Canick JA; Blitzer MG; Palomaki GE; Schwartz S; Blakemore KJ; Haddow JE
    Prenat Diagn; 1999 Sep; 19(9):813-6. PubMed ID: 10521837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum screening for birth defects: results of a Connecticut regional program.
    Benn PA; Horne D; Craffey A; Collins R; Ramsdell L; Greenstein R
    Conn Med; 1996 Jun; 60(6):323-7. PubMed ID: 8706425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA; Ying J; Beazoglou T; Egan JF
    Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
    Talbot JA; Spencer K; Abushoufa RA
    Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
    Frishman GN; Canick JA; Hogan JW; Hackett RJ; Kellner LH; Saller DN
    Obstet Gynecol; 1997 Jul; 90(1):98-101. PubMed ID: 9207822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21.
    Borrell A; Mercade I; Casals E; Borobio V; Seres A; Soler A; Fortuny A; Cuckle H
    Ultrasound Obstet Gynecol; 2007 Dec; 30(7):941-5. PubMed ID: 18000942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD; McIntosh SF; Halstead AC
    Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects.
    Saller DN; Canick JA; Palomaki GE; Knight GJ; Haddow JE
    Obstet Gynecol; 1994 Nov; 84(5):852-5. PubMed ID: 7524003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
    Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.